Anne O’Dea

1.6k total citations
45 papers, 716 citations indexed

About

Anne O’Dea is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Anne O’Dea has authored 45 papers receiving a total of 716 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Oncology, 23 papers in Cancer Research and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Anne O’Dea's work include Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (11 papers) and Cancer Genomics and Diagnostics (10 papers). Anne O’Dea is often cited by papers focused on Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (11 papers) and Cancer Genomics and Diagnostics (10 papers). Anne O’Dea collaborates with scholars based in United States, Australia and Belgium. Anne O’Dea's co-authors include Qamar J. Khan, Priyanka Sharma, Bruce F. Kimler, Carol J. Fabian, Jennifer R. Klemp, Pavan S. Reddy, Jamie L. Wagner, Lauren Nye, Kelsey E. Larson and Christa Balanoff and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Anne O’Dea

38 papers receiving 704 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne O’Dea United States	14	445	233	207	133	106	45	716
Annamaria Molino Italy	17	516 1.2×	348 1.5×	106 0.5×	125 0.9×	70 0.7×	38	875
Po‐Han Lin Taiwan	17	263 0.6×	219 0.9×	208 1.0×	75 0.6×	135 1.3×	38	784
P. Neven Belgium	14	531 1.2×	222 1.0×	192 0.9×	45 0.3×	189 1.8×	24	836
Bo Lan China	14	619 1.4×	160 0.7×	328 1.6×	78 0.6×	48 0.5×	54	919
Lola Anagnostaki Sweden	18	435 1.0×	314 1.3×	104 0.5×	162 1.2×	110 1.0×	38	861
Matilde Pensabene Italy	16	234 0.5×	141 0.6×	194 0.9×	68 0.5×	161 1.5×	35	597
Allen M. Vukov United States	9	511 1.1×	145 0.6×	134 0.6×	274 2.1×	118 1.1×	9	847
Tarah J. Ballinger United States	13	383 0.9×	217 0.9×	159 0.8×	45 0.3×	84 0.8×	49	727
M Gerstenhauer Germany	7	262 0.6×	259 1.1×	93 0.4×	108 0.8×	55 0.5×	7	609
Reinaldo Chacón Argentina	13	302 0.7×	151 0.6×	92 0.4×	59 0.4×	79 0.7×	26	580

Countries citing papers authored by Anne O’Dea

Since Specialization

Citations

This map shows the geographic impact of Anne O’Dea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne O’Dea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne O’Dea more than expected).

Fields of papers citing papers by Anne O’Dea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne O’Dea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne O’Dea. The network helps show where Anne O’Dea may publish in the future.

Co-authorship network of co-authors of Anne O’Dea

This figure shows the co-authorship network connecting the top 25 collaborators of Anne O’Dea. A scholar is included among the top collaborators of Anne O’Dea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne O’Dea. Anne O’Dea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stecklein, Shane R., Roberto Salgado, Julia White, et al.. (2025). Analysis of the Radiosensitivity Index in Paired Preneoadjuvant and Postneoadjuvant Therapy Triple-Negative Breast Cancer. International Journal of Radiation Oncology*Biology*Physics. 124(3). 717–725.

Stecklein, Shane R., Roberto Salgado, Anne O’Dea, et al.. (2024). NeoTRACT: Phase II trial of neoadjuvant tumor infiltrating lymphocyte- and response-adapted chemoimmunotherapy for triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 42(16_suppl). TPS629–TPS629. 3 indexed citations

Larson, Kelsey E., Christa Balanoff, Lauren Nye, et al.. (2023). Use of Ultrasound and Ki–67 Proliferation Index to Predict Breast Cancer Tumor Response to Neoadjuvant Endocrine Therapy. Healthcare. 11(3). 417–417. 4 indexed citations

Stecklein, Shane R., Bruce F. Kimler, Rachel Yoder, et al.. (2023). ctDNA and residual cancer burden are prognostic in triple-negative breast cancer patients with residual disease. npj Breast Cancer. 9(1). 10–10. 16 indexed citations

Stecklein, Shane R., Devin C. Koestler, Nanda Kumar Yellapu, et al.. (2023). Extracellular vesicle-derived non-coding RNAs to predict outcome in patients with triple-negative breast cancer (TNBC) with residual disease (RD).. Journal of Clinical Oncology. 41(16_suppl). 578–578. 3 indexed citations

Sharma, Priyanka, Shane R. Stecklein, Rachel Yoder, et al.. (2023). Abstract PD11-07: PD11-07 Association of TNBC-DX scores with outcomes in triple-negative breast cancer (TNBC) treated with neoadjuvant pembrolizumab and chemotherapy: a correlative analysis from NeoPACT and NeoSTOP trials. Cancer Research. 83(5_Supplement). PD11–7. 2 indexed citations

Koshy, Abraham, et al.. (2023). 51 Home-collected sputum samples for Aspergillus fumigatus detection in adults with cystic fibrosis. Journal of Cystic Fibrosis. 22. S27–S28. 1 indexed citations

Griffiths, Jason I., Jinfeng Chen, Patrick A. Cosgrove, et al.. (2021). Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy. Nature Cancer. 2(6). 658–671. 41 indexed citations

Myers, Jamie, Melissa P. Mitchell, Junqiang Dai, et al.. (2020). Pilot Feasibility Study Examining Pupillary Response During Driving Simulation as a Measure of Cognitive Load in Breast Cancer Survivors. Oncology nursing forum. 47(2). 203–212. 3 indexed citations

10.

Nye, Lauren, Anne O’Dea, Priyanka Sharma, et al.. (2020). Incorporating of telementoring (Project ECHO) into practice: Efficacy of Point Of Service Testing-Breast Cancer (ePOST-BC).. Journal of Clinical Oncology. 38(29_suppl). 113–113.

11.

Khan, Qamar J., Anne O’Dea, Aditya Bardia, et al.. (2020). Letrozole + ribociclib versus letrozole + placebo as neoadjuvant therapy for ER+ breast cancer (FELINE trial).. Journal of Clinical Oncology. 38(15_suppl). 505–505. 47 indexed citations

12.

Parletta, Natalie, Dorota Zarnowiecki, Ji‐Hyun Cho, et al.. (2018). A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: A randomised controlled trial (HELFIMED). 37(1). 6. 3 indexed citations

13.

Amin, Amanda L., Christa Balanoff, Kelsey E. Larson, et al.. (2018). Reducing Breast Cancer-Related Lymphedema (BCRL) Through Prospective Surveillance Monitoring Using Bioimpedance Spectroscopy (BIS) and Patient Directed Self-Interventions. Annals of Surgical Oncology. 25(10). 2948–2952. 62 indexed citations

14.

Myers, Jamie, Melissa P. Mitchell, Junqiang Dai, et al.. (2018). Pupillary response: cognitive effort for breast cancer survivors. Supportive Care in Cancer. 27(3). 1121–1128. 6 indexed citations

15.

Sharma, Priyanka, Vandana G. Abramson, Anne O’Dea, et al.. (2018). Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 1018–1018. 21 indexed citations

16.

Sharma, Priyanka, Anne O’Dea, Susan E. Lewis, et al.. (2017). Abstract P6-11-08: Safety and efficacy results from phase I study of BYL 719 plus nab-paclitaxel in HER 2 negative metastatic breast cancer. Cancer Research. 77(4_Supplement). P6–11. 3 indexed citations

17.

Tawfik, Ossama, Bruce F. Kimler, Marilyn Davis, et al.. (2010). Clinicopathological characteristics of triple-negative invasive mammary carcinomas in African-American versus Caucasian women.. PubMed. 40(4). 315–23. 15 indexed citations

18.

Khan, Qamar J., Pavan S. Reddy, Bruce F. Kimler, et al.. (2009). Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Research and Treatment. 119(1). 111–118. 146 indexed citations

19.

Khan, Qamar J., Bruce F. Kimler, Anne O’Dea, et al.. (2007). Mammographic density does not correlate with Ki-67 expression or cytomorphology in benign breast cells obtained by random periareolar fine needle aspiration from women at high risk for breast cancer. Breast Cancer Research. 9(3). R35–R35. 32 indexed citations

20.

Klemp, Jennifer R., et al.. (2005). Patient Satisfaction of BRCA1/2 Genetic Testing by Women at High Risk for Breast Cancer Participating in a Prevention Trial. Familial Cancer. 4(4). 279–284. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact